Literature DB >> 36006458

Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience.

Yusuf Karabulut1, Nuran Öz2, Halise Hande Gezer3, İrfan Esen4, Mehmet Tuncay Duruöz2.   

Abstract

Sarcoidosis may present with many rheumatological symptoms as well as mimic and/or may occur concomitantly with many other rheumatic diseases. We examined the demographic, clinical and laboratory characteristics of patients diagnosed with sarcoidosis in the rheumatology department. This study planned as retrospective cross-sectional study. Medical records of patients who applied to our rheumatology outpatient clinic due to complain of musculoskeletal problems and then diagnosed sarcoidosis were retrospectively investigated. Joint findings, extrapulmonary involvements, and coexisting rheumatic disease were evaluated. Fifty-six patients (41.21 ± 7.83 years, 75% female) were included. The duration of the disease was 49.61 ± 29.11 months, and the follow-up period was 26.66 ± 13.26 months. All patients had pulmonary system involvement. Arthralgia was present in 91.10% of 56 patients and arthritis in 89.29% of patients. Examining the subtypes of the arthritis findings, mono-arthritis was found in 31/50 (62%) patients, oligo-arthritis in 15/50 (30%) patients, and polyarthritis in 4/50 (8%) patients. A total of 11 (19.60%) patients were diagnosed with uveitis. Excision of the mediastinal LAP was performed in a total of 37 patients (66.1%) and became the most commonly employed method. Considering the treatment distribution of the patients under followed-up, it is seen that non-steroidal anti-inflammatory treatments were used in 15 (26.8%) patients, corticosteroids in a total of 40 (71.4%) patients, methotrexate in a total of 15 patients (26.8%), azathioprine in six (10.7%) patients, hydroxychloroquine in 14 (25%) patients, and infliximab in one (1.8%) patient. As sarcoidosis is a mimicking disease, a good differential diagnosis should be made to avoid misdiagnosis and in order not to be late in diagnosis and treatment. Physicians, especially rheumatologists, should remember sarcoidosis more frequently as the disease may overlap with other rheumatological diseases and may occur with many rheumatological manifestations.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Arthritis; Organ ınvolvement; Sarcoidosis; Uveitis

Mesh:

Substances:

Year:  2022        PMID: 36006458     DOI: 10.1007/s00296-022-05193-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  43 in total

Review 1.  Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us?

Authors:  Y Hosoda; M Yamaguchi; Y Hiraga
Journal:  Clin Chest Med       Date:  1997-12       Impact factor: 2.878

Review 2.  Morbidity and mortality in sarcoidosis.

Authors:  Alicia K Gerke
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

3.  Sarcoidois: is it only a mimicker of primary rheumatic disease? A single center experience.

Authors:  Senol Kobak; Fidan Sever; Oya Nermin Sivrikoz; Mehmet Orman
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-02       Impact factor: 5.346

Review 4.  Sarcoidosis.

Authors:  Johan Grunewald; Jan C Grutters; Elizabeth V Arkema; Lesley Ann Saketkoo; David R Moller; Joachim Müller-Quernheim
Journal:  Nat Rev Dis Primers       Date:  2019-07-04       Impact factor: 52.329

5.  Epidemiological features of Turkish patients with sarcoidosis.

Authors:  B Musellim; O O Kumbasar; G Ongen; E Cetinkaya; H Turker; E Uzaslan; E Yenturk; O Uzun; L Saglam; G Celik; G Okumus; A N Annakkaya; G Altiay; L Tabak; A Sakar; G Kiter; S Erturan; H Turktas; E Yalniz; A Akkoclu; C Ogus; O T Dogan; M Ozkan; S Aktogu; I Uzel
Journal:  Respir Med       Date:  2009-02-01       Impact factor: 3.415

Review 6.  Sarcoidosis and the rheumatologist.

Authors:  Karina D Torralba; Francisco P Quismorio
Journal:  Curr Opin Rheumatol       Date:  2009-01       Impact factor: 5.006

7.  Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing.

Authors:  Davendra Mehta; Steven A Lubitz; Zev Frankel; Juan P Wisnivesky; Andrew J Einstein; Martin Goldman; Josef Machac; Alvin Teirstein
Journal:  Chest       Date:  2008-03-13       Impact factor: 9.410

8.  Cardiac sarcoidosis: diagnosis and management.

Authors:  Michelle Bussinguer; Alfred Danielian; Om P Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

9.  Ocular involvement in sarcoidosis.

Authors:  Leyla S Atmaca; Pelin Atmaca-Sönmez; Aysun Idil; Ozlem O Kumbasar; Gökhan Celik
Journal:  Ocul Immunol Inflamm       Date:  2009 Mar-Apr       Impact factor: 3.070

10.  Effects of Prone Ventilation on Oxygenation, Inflammation, and Lung Infiltrates in COVID-19 Related Acute Respiratory Distress Syndrome: A Retrospective Cohort Study.

Authors:  Rohit Khullar; Shrey Shah; Gagandeep Singh; Joseph Bae; Rishabh Gattu; Shubham Jain; Jeremy Green; Thiruvengadam Anandarangam; Marc Cohen; Nikhil Madan; Prateek Prasanna
Journal:  J Clin Med       Date:  2020-12-21       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.